Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03197506
Title Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

gliosarcoma

glioblastoma

Therapies

Pembrolizumab + Temozolomide

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.